List of works - Mona Munteanu

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

scientific article

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

scientific article

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

scientific article

Applicability and variability of liver stiffness measurements according to probe position

scientific article published on July 2009

Assessment of liver fibrosis: noninvasive means

scientific article published on October 2008

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

scientific article

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

scientific article published in February 2005

Biomarkers of liver fibrosis

scientific article published on January 2008

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

scientific article

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

scientific article

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

scientific article published on 23 August 2016

Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference

scientific article published on 5 February 2018

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

scientific article

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

scientific article

FibroMAX: towards a new universal biomarker of liver disease?

scientific article published on September 2007

FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted

scientific article published on 2 February 2011

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program

scientific article published on 15 September 2010

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection

scientific article

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

scientific article

Hirsch index and truth survival in clinical research

scientific article

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

scientific article published on 04 November 2019

Impact of steatosis and inflammation definitions on the performance of NASH tests.

scientific article published in April 2018

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

scientific article published on 29 June 2010

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

scientific article

Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection

scientific article

Meta-analyses of FibroTest diagnostic value in chronic liver disease

scientific article

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

scientific article

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

scientific article published in October 2007

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

scientific article

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

scientific article

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

scientific article

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

scientific article

Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?

scientific article published on 8 April 2011

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

scientific article

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.

scientific article

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

scientific article published on 6 August 2013

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

scientific article published on 24 May 2013

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

scientific article

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

scientific article

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

scientific article published on 18 May 2012

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

scientific article published on 9 June 2014

List of works by Mona Munteanu

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

Applicability and variability of liver stiffness measurements according to probe position

Assessment of liver fibrosis: noninvasive means

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

Biomarkers of liver fibrosis

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

FibroMAX: towards a new universal biomarker of liver disease?

FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

Hirsch index and truth survival in clinical research

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

Impact of steatosis and inflammation definitions on the performance of NASH tests.

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection

Meta-analyses of FibroTest diagnostic value in chronic liver disease

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".